Login/Register
English
简体中文
English
한국어
日本語
News Activities
Your Location： Homepage > About Us > News Activities

Zhao Yan, Chairman of Bloomage Biotech- National Examination and Approval System Should Help Enterprise Innovation

2019.03.11


Zhao Yan, Chairman of Bloomage Biotech: National Examination and Approval System Should Help Enterprise Innovation

On March 8, the Symposium on Innovating Medicine Development to Assist Health in China—2019 National Medical and Pharmaceutical Representative Committee was held in the New Media Building of People's Daily under the guidance of People's Daily. It was sponsored by People's Daily Online and Health Times, attended by representatives and committee members from the fields of government management, medicine and industry, as well as some medical and health industry personages.

会议室里的人们 描述已自动生成

Zhao Yan, Chairman of Bloomage Biotech, said that the development of innovative enterprises could not be separated from the support of national supervision system during dialogue and communication with delegates and committee members. At the same time, the innovation and development of enterprises also needed the support of the national regulatory authorities in examination and approval and other aspects.

女人在喝饮料 中度可信度描述已自动生成

Zhao Yan introduced that Bloomage Biotech was a leading enterprise in the production of hyaluronic acid commonly known as hyaluronic acid in China. After 20 years of development, it had formed two business segments of raw materials and terminal products. The annual investment in research and development was very considerable. It was one of the few domestic manufacturers that had obtained approval numbers of pharmaceutical excipients and raw materials for the production of hyaluronic acid by fermentation. Manufacturers that had passed the new GMP certification of China and obtained the HA production qualification of new food raw materials. At the same time, it is also an important member participating in drafting a number of industry standards for hyaluronic acid. Thanks to national support.

However, there are also difficulties in the process of innovation and development at present. For example, hyaluronic acid is a substance contained in human body itself and proved to be a very safe substance. It has been applied in raw materials of medicine, medical equipment and skin care industry for nearly 20 years. But it has not been approved for 20 years in food field. This limits the innovation and development of the industry to a certain extent.

It is hoped that through the dialogue, the representative committee members can provide suggestions in the innovative development of enterprises, and obtain the support from the national system level. 

Previous：Invited Davos Forum_Zhao Yan, Chairman of Bloomage Biotech- Promoting High Quality Development with New Leadership Next：Chairman Zhao attended the Seminar of Medical and Pharmaceutical Representatives of the 2019 NPC and CPPCC